Qaelon Medical, a company that develops real-time tools for detecting surgical leaks and advanced insufflation systems, has announced that Dr. Joel Dunning will join its Scientific Advisory Board. Dr. Dunning, a well-known expert in thoracic and robotic surgery, will help with the clinical development of Qaelon’s platform, which aims to improve the detection and identification of leaks during minimally invasive surgeries, such as those in thoracic and robotic procedures. His joining comes after Dr. Andrew Storm, who is the Chair of Endoscopy at the Mayo Clinic in Rochester, Minnesota, was also added to the board.
Health Technology Insights: Scott Rairigh Joins Psilera as Corporate Development Lead
Eran Shlomovitz, the Chief Medical Officer and Founder of Qaelon Medical, is excited about this new addition. He believes that having someone with Dr. Dunning’s experience in thoracic and robotic surgery is a big step forward for the company. According to Dr. Shlomovitz, Dr. Dunning’s reputation and contributions to advancing minimally invasive techniques make him an ideal fit as Qaelon continues to improve its technology for quickly and precisely finding surgical leaks during high-risk procedures.
Health Technology Insights: Zydus and Synthon Partner for Ozanimod Capsules in U.S. Market
Dr. Dunning practices thoracic surgery at James Cook University Hospital in the UK. He is known for his work in minimally invasive thoracic techniques and regularly trains surgical teams in robotic thoracic procedures for companies like Intuitive and Cambridge Medical Robotics. He studied medicine at Oxford University and earned a PhD from Manchester University. In addition to being Editor in Chief of CTSNet for the past two years, he has co-written several important guidelines in cardiothoracic surgery. Dr. Dunning also created the Cardiothoracic Advanced Life Support course, which is held many times a year worldwide. His commitment to global health includes leading heart surgery missions to Ghana since 2019 and running the Pace4life charity, which last year installed 200 used pacemakers for patients in need.
Dr. Dunning is enthusiastic about his new role and is eager to help develop technologies that can change the future of thoracic surgery. He believes that prolonged air leaks are one of the biggest challenges in the field, often going unnoticed with serious effects on patients. He notes that Qaelon’s approach using real-time data and advanced insufflation meets a crucial need, particularly as thoracic surgeries become more minimally invasive. Dr. Dunning is looking forward to working with other members of the Scientific Advisory Board to boost the impact of Qaelon’s technology on surgical safety and results.
Liam Burns, Chief Executive Officer of Qaelon Medical, said the company’s long-term goal is to make real-time leak detection and accurate leak location a standard part of all minimally invasive surgeries. He emphasized that input from experts like Dr. Dunning is essential to changing surgical practices from reactive to proactive, data-based strategies. Burns believes this marks an important milestone in Qaelon’s mission to bring leak detection into the digital age and set a new standard for safety and efficiency in operating rooms.
Health Technology Insights: Proprio Welcomes Adam Spice, Rocket Lab CFO, as Board Member
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
